Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David de la Rosa

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Revista Espanola De Salud Publica|October 22, 2021
[COVID-19: modification of the risk of infection and disease development associated with the performance of blended work.]David de la Rosa Ruiz, Carlos Antonio Guillén Astete
Perceptual and Motor Skills|April 15, 2014
Influence of prior use of the same or different effectors in a reaching actionGermán Gálvez-García, Catherine Gabaude, Francisco David de la Rosa, et al.
Scandinavian Journal of Work, Environment & Health|April 27, 2007
Occupational vocal cord dysfunction due to exposure to wood dust and xerographic tonerXavier Muñoz, Alex Roger, David De la Rosa, et al.
Open Respiratory Archives|July 27, 2023
Immunosenescence, Immune Fitness and Vaccination Schedule in the Adult Respiratory PatientFelipe Villar-Álvarez, David de la Rosa-Carrillo, Fernando Fariñas-Guerrero, et al.
Respiratory Medicine|July 12, 2003
Use of endoscopic fibrinogen-thrombin in the treatment of severe hemoptysisJavier de Gracia, David de la Rosa, Edelia Catalán, et al.
Open Respiratory Archives|July 27, 2023
Systematic Review of Systemic Corticosteroids for Treatment of Organizing PneumoniaLaia Cendon, Albert Rafecas Codern, David de la Rosa, et al.
Expert Review of Respiratory Medicine|May 29, 2018
Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasisRodrigo Athanazio, Joao Cordeiro da Costa, David de la Rosa Carrillo, et al.
Chronic Respiratory Disease|April 14, 2016
Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistenceDavid de la Rosa, Miguel-Angel Martínez-Garcia, Casilda Olveira, et al.
Archivos De Bronconeumologia|September 30, 2022
Pathophysiology of Chronic Bronchial Infection in BronchiectasisBelén Solarat, Lidia Perea, Rosa Faner, et al.
Infection and Drug Resistance|December 21, 2022
Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by <i>Pseudomonas aeruginosa</i>: A Narrative Review of Current EvidenceDavid de la Rosa-Carrillo, Guillermo Suárez-Cuartín, Rafael Golpe, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Revista Espanola De Salud Publica|October 22, 2021
[COVID-19: modification of the risk of infection and disease development associated with the performance of blended work.]David de la Rosa Ruiz, Carlos Antonio Guillén Astete
Perceptual and Motor Skills|April 15, 2014
Influence of prior use of the same or different effectors in a reaching actionGermán Gálvez-García, Catherine Gabaude, Francisco David de la Rosa, et al.
Scandinavian Journal of Work, Environment & Health|April 27, 2007
Occupational vocal cord dysfunction due to exposure to wood dust and xerographic tonerXavier Muñoz, Alex Roger, David De la Rosa, et al.
Open Respiratory Archives|July 27, 2023
Immunosenescence, Immune Fitness and Vaccination Schedule in the Adult Respiratory PatientFelipe Villar-Álvarez, David de la Rosa-Carrillo, Fernando Fariñas-Guerrero, et al.
Respiratory Medicine|July 12, 2003
Use of endoscopic fibrinogen-thrombin in the treatment of severe hemoptysisJavier de Gracia, David de la Rosa, Edelia Catalán, et al.
Open Respiratory Archives|July 27, 2023
Systematic Review of Systemic Corticosteroids for Treatment of Organizing PneumoniaLaia Cendon, Albert Rafecas Codern, David de la Rosa, et al.
Expert Review of Respiratory Medicine|May 29, 2018
Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasisRodrigo Athanazio, Joao Cordeiro da Costa, David de la Rosa Carrillo, et al.
Chronic Respiratory Disease|April 14, 2016
Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistenceDavid de la Rosa, Miguel-Angel Martínez-Garcia, Casilda Olveira, et al.
Archivos De Bronconeumologia|September 30, 2022
Pathophysiology of Chronic Bronchial Infection in BronchiectasisBelén Solarat, Lidia Perea, Rosa Faner, et al.
Infection and Drug Resistance|December 21, 2022
Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by <i>Pseudomonas aeruginosa</i>: A Narrative Review of Current EvidenceDavid de la Rosa-Carrillo, Guillermo Suárez-Cuartín, Rafael Golpe, et al.
Pageof 8